Introduction Gastroesophageal reflux disease (GERD) is a chronic disease of the
esophagus characterized by the regurgitation of stomach contents into the esophagus …

Description The purpose of this American Gastroenterological Association (AGA) Institute
Clinical Practice Update (CPU) is to summarize the available evidence and offer expert Best …

Gastroesophageal reflux disease (GERD) is common, with increasing worldwide disease
prevalence and high economic burden. A significant number of patients will remain …

Background Oesophageal disorders and chronic liver disease are common worldwide and
significantly impact quality of life. The intricate link between these conditions, including how …

Gastroesophageal reflux disease (GERD), a prevalent clinical condition, is often attributed to
aberrant esophageal motility, leading to gastric content reflux and associated symptoms or …

The relationship between food and the pathophysiological mechanisms of
gastroesophageal reflux disease (GERD) is unclear. There are few data on the impact of …

Background: This review addresses the intricate spectrum of gastroesophageal reflux
disease (GERD), a condition affecting 10–30% of the Western population. GERD is …

ABSTRACT Introduction Proton pump inhibitors (PPIs) are the first-line treatment for
gastroesophageal reflux disease (GERD). However, due to their intrinsic limitations, there …

Background The diagnosis of gastro‐oesophageal reflux disease (GERD) based on
otolaryngologist's assessment of laryngoscopic findings remains contentious in terms of …

Background: Despite deprescribing initiatives to curb overutilization of proton pump
inhibitors (PPIs), achieving meaningful reductions in PPI use is proving a challenge …